26 Oct 2020
// BIOSPACE
https://www.biospace.com/article/releases/new-pediatric-and-secondary-endpoint-data-from-rivipansel-phase-3-reset-trial-presented-at-the-annual-scientific-conference-on-sickle-cell-and-thalassemia-ascat-meeting/
12 Jun 2020
// BUSINESSWIRE
06 Aug 2019
// Ben Adams FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/glycomimetics-nearly-cut-half-as-pfizer-partnered-phase-3-drug-flops
02 Aug 2019
// BUSINESSWIRE
06 May 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/medicines360-and-allergan-present-six-year-clinical-data-from-largest-ongoing-phase-3-study-of-an-intrauterine-system-in-the-us-300843478.html
04 Jul 2018
// FORBES
https://www.forbes.com/sites/greatspeculations/2018/07/02/how-sensitive-is-pfizer-to-rd-expense-changes/#1a6f7f16230f